TY - JOUR
T1 - Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
AU - Stamberger, Hannah
AU - Crosiers, David
AU - Balagura, Ganna
AU - Bonardi, Claudia M
AU - Basu, Anna
AU - Cantalupo, Gaetano
AU - Chiesa, Valentina
AU - Christensen, Jakob
AU - Dalla Bernardina, Bernardo
AU - Ellis, Colin A
AU - Furia, Francesca
AU - Gardiner, Fiona
AU - Giron, Camille
AU - Guerrini, Renzo
AU - Klein, Karl Martin
AU - Korff, Christian
AU - Krijtova, Hana
AU - Leffner, Melanie
AU - Lerche, Holger
AU - Lesca, Gaetan
AU - Lewis-Smith, David
AU - Marini, Carla
AU - Marjanovic, Dragan
AU - Mazzola, Laure
AU - McKeown Ruggiero, Sarah
AU - Mochel, Fanny
AU - Ramond, Francis
AU - Reif, Philipp S
AU - Richard-Mornas, Aurélie
AU - Rosenow, Felix
AU - Schropp, Christian
AU - Thomas, Rhys H
AU - Vignoli, Aglaia
AU - Weber, Yvonne
AU - Palmer, Elizabeth
AU - Helbig, Ingo
AU - Scheffer, Ingrid E
AU - Striano, Pasquale
AU - Møller, Rikke S
AU - Gardella, Elena
AU - Weckhuysen, Sarah
N1 - Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
PY - 2022/7/19
Y1 - 2022/7/19
N2 - BACKGROUND AND OBJECTIVES: Pathogenic STXBP1 variants cause a severe early-onset developmental and epileptic encephalopathy (STXBP1-DEE). We aimed to investigate the natural history of STXBP1-DEE in adults focusing on seizure evolution, the presence of movement disorders, and the level of functional (in)dependence.METHODS: In this observational study, patients with a minimum age of 18 years carrying a (likely) pathogenic STXBP1 variant were recruited through medical genetics departments and epilepsy centers. Treating clinicians completed clinical questionnaires and performed semistructured video examinations while performing tasks from the (modified) Unified Parkinson Disease Rating Scale when possible.RESULTS: Thirty adult patients were included for summary statistics, with video recordings available for 19 patients. The median age at last follow-up was 24 years (range 18-58 years). All patients had epilepsy, with a median onset age of 3.5 months. At last follow-up, 80% of adults had treatment-resistant seizures despite long periods of seizure freedom in 37%. Tonic-clonic, focal, and tonic seizures were most frequent in adults. Epileptic spasms, an unusual feature beyond infancy, were present in 3 adults. All individuals had developmental impairment. Periods of regression were present in 59% and did not always correlate with flare-ups in seizure activity. Eighty-seven percent had severe or profound intellectual disability, 42% had autistic features, and 65% had significant behavioral problems. Video examinations showed gait disorders in all 12 patients able to walk, including postural abnormalities with external rotation of the feet, broad-based gait, and asymmetric posture/dystonia. Tremor, present in 56%, was predominantly of the intention/action type. Stereotypies were seen in 63%. Functional outcome concerning mobility was variable ranging from independent walking (50%) to wheelchair dependence (39%). Seventy-one percent of adults were nonverbal, and all were dependent on caregivers for most activities of daily living.DISCUSSION: STXBP1-DEE warrants continuous monitoring for seizures in adult life. Periods of regression are more frequent than previously established and can occur into adulthood. Movement disorders are often present and involve multiple systems. Although functional mobility is variable in adulthood, STXBP1-DEE frequently leads to severe cognitive impairments and a high level of functional dependence. Understanding the natural history of STXBP1-DEE is important for prognostication and will inform future therapeutic trials.
AB - BACKGROUND AND OBJECTIVES: Pathogenic STXBP1 variants cause a severe early-onset developmental and epileptic encephalopathy (STXBP1-DEE). We aimed to investigate the natural history of STXBP1-DEE in adults focusing on seizure evolution, the presence of movement disorders, and the level of functional (in)dependence.METHODS: In this observational study, patients with a minimum age of 18 years carrying a (likely) pathogenic STXBP1 variant were recruited through medical genetics departments and epilepsy centers. Treating clinicians completed clinical questionnaires and performed semistructured video examinations while performing tasks from the (modified) Unified Parkinson Disease Rating Scale when possible.RESULTS: Thirty adult patients were included for summary statistics, with video recordings available for 19 patients. The median age at last follow-up was 24 years (range 18-58 years). All patients had epilepsy, with a median onset age of 3.5 months. At last follow-up, 80% of adults had treatment-resistant seizures despite long periods of seizure freedom in 37%. Tonic-clonic, focal, and tonic seizures were most frequent in adults. Epileptic spasms, an unusual feature beyond infancy, were present in 3 adults. All individuals had developmental impairment. Periods of regression were present in 59% and did not always correlate with flare-ups in seizure activity. Eighty-seven percent had severe or profound intellectual disability, 42% had autistic features, and 65% had significant behavioral problems. Video examinations showed gait disorders in all 12 patients able to walk, including postural abnormalities with external rotation of the feet, broad-based gait, and asymmetric posture/dystonia. Tremor, present in 56%, was predominantly of the intention/action type. Stereotypies were seen in 63%. Functional outcome concerning mobility was variable ranging from independent walking (50%) to wheelchair dependence (39%). Seventy-one percent of adults were nonverbal, and all were dependent on caregivers for most activities of daily living.DISCUSSION: STXBP1-DEE warrants continuous monitoring for seizures in adult life. Periods of regression are more frequent than previously established and can occur into adulthood. Movement disorders are often present and involve multiple systems. Although functional mobility is variable in adulthood, STXBP1-DEE frequently leads to severe cognitive impairments and a high level of functional dependence. Understanding the natural history of STXBP1-DEE is important for prognostication and will inform future therapeutic trials.
KW - Activities of Daily Living
KW - Adolescent
KW - Adult
KW - Electroencephalography
KW - Epilepsy
KW - Humans
KW - Infant
KW - Middle Aged
KW - Movement Disorders/genetics
KW - Munc18 Proteins/genetics
KW - Mutation
KW - Seizures/genetics
KW - Young Adult
U2 - 10.1212/WNL.0000000000200715
DO - 10.1212/WNL.0000000000200715
M3 - Article
C2 - 35851549
SN - 0028-3878
VL - 99
SP - e221-e233
JO - Neurology
JF - Neurology
IS - 3
ER -